References
- Li H, Gray BD, Corbin I, et al. Mr and fluorescent imaging of low-density lipoprotein receptors1. Acad Radiol. 2004;11(11):1251–1259.
- Cormode DP, Jarzyna PA, Mulder W,JM, et al. Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev. 2010;62(3):329–338.
- Chen W, Cormode DP, Fayad ZA, et al. Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3(2):146–161.
- Corbin IR, Ng KK, Ding L, et al. Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers. Nanomedicine (Lond). 2013;8(6):875–890.
- Song L, Li H, Sunar U, et al. Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. J Int Nanomedicine. 2007;2(4):767–774.
- Almer G, Mangge H, Zimmer A, et al. J. Curr Med Chem. 1015, 22(31):3631–3651.
- Simonetta GC, Stefania L, Diego A, et al. Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles. Neoplasia. 2007;9(12):1046–1056.
- Ng KK, Lovell JF, Zheng. J G. Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res. 2011;44(10):1105–1113.
- Corbin IR, Li H, Chen J, et al. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia. 2006;8(6):488–498.
- Thaxton CS, Rink JS, Naha PC, et al. Lipoproteins and lipoprotein mimetics for imaging and drug delivery. J. Adv Drug Delivery Rew. 2016;106:116–131.
- Lowell AN, Qiao H, Liu T, et al. Functionalized Low-Density lipoprotein nanoparticles for in vivo enhancement of atherosclerosis on magnetic resonance images. Bioconjugate Chem. 2012;23(11):2313–2319.
- Mehravi B, Alizadeh AM, Khodayari S, et al. J Mol Imaging Biol. 2017; 19:522–530.